Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder

This study has been completed.

Study NCT00061802 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: June 4, 2003 Last Updated: December 1, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	February 2004
Estimated Primary Completion Date:	No date given